SNN Smith & Nephew Earnings and EPS analysis

Relative Growth: Rel. Growth: 61

Relative Strength: Rel. Strength: 27

Relative Valuation: Rel. Valuation: 78

Relative Profitability: Rel. Profitability: 81

EPS in 2026 (TTM): $1.44

Last Report Period Date: Dec 31, 2025

Currently, SNN's trailing twelve months (TTM) EPS stands at $1.44, according to the most recent financial reports. In 2025, SNN reported a per-share earnings of $1.44, which represents an increase compared to the EPS of $0.94 recorded in 2024.

SNN earnings history

Historical annual and quarterly earnings per share (EPS) data for Smith & Nephew

EPS (TTM)

$1.44

In 2025, Smith & Nephew's EPS was $1.44, an increase of 53.2% from $0.94 in 2024. The trailing twelve months (TTM) EPS as of December 2025 is $1.44. In 2024, the annual EPS was $0.94, showing an increase of 56.7% compared to 2023.

SNN earnings chart

SNN EPS growth history

Earnings per share growth rates over time

EPS growth YoY

53.2%

EPS growth 3Y avg

41.3%

EPS growth 5Y avg

6.9%

Looking at a longer timeframe, the company recorded an average EPS annual growth rate of 41.3% per year for the last 3 years. Over the last five years, the company had an average annual EPS growth of 6.9%. A ten-year view shows that SNN has seen an average earnings per share growth of 4.6% per year.

SNN Earnings Waterfall

Breakdown of revenue, profit and net income for Smith & Nephew

SNN Earnings vs Peers

What are the earnings of SNN compared to its peers

Stock name	Price to Earnings	EPS grwoth 1Y	EPS grwoth 3Y	EPS grwoth 5Y
BSX Boston Scientific Corp	18.73	55.6%	63.3%	N/A
SNN Smith & Nephew plc	21.01	53.2%	41.3%	6.9%
MDT Medtronic plc	22.18	3.3%	9.8%	6.9%
ZBH Zimmer Biomet Holdings Inc	22.6	-20%	47.9%	N/A
ABT Abbott Laboratories	26.57	-51.4%	-1.8%	8.2%
JNJ Johnson & Johnson	30.13	90.6%	17.7%	14.8%
SYK Stryker Corp	37.36	8%	10.9%	14.8%
BDX Becton Dickinson & Co	40.02	-0.9%	-0.6%	16.2%
EW Edwards Lifesciences Corp	49.93	-73.6%	-9.2%	6.9%
ISRG Intuitive Surgical Inc	50.96	22.3%	29.1%	21.5%
BAX Baxter International Inc	N/A	-47.2%	N/A	N/A

All data is based on quarterly TTM periods, unless otherwise specified.